UChicago Cancer
@uchicagocancer.bsky.social
Joint account for the NCI-designated UChicago Medicine Comprehensive Cancer Center and the University of Chicago's Section of Hematology/Oncology.
At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
At the forefront of clinical care, research, and education. https://www.uchicagomedicine.org/cancer
Two patients diagnosed with prostate cancer chose HIFU — a precise, non-invasive therapy — and both avoided major side effects while treating their cancer.
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
November 25, 2025 at 5:43 PM
Two patients diagnosed with prostate cancer chose HIFU — a precise, non-invasive therapy — and both avoided major side effects while treating their cancer.
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
Learn how UChicago Medicine is leading the way in focal therapy: https://ow.ly/St3x50XxF0c
@UChicagoMedicine
Congratulations to Tre Jones for this award and we are grateful for his support of cancer research! https://nbpa.com/news/chicago-bulls-tre-jones-named-nba-cares-bob-lanier-community-assist-award-winner-for-october
CHICAGO BULLS’ TRE JONES NAMED NBA CARES BOB LANIER COMMUNITY ASSIST AWARD WINNER FOR OCTOBER
The National Basketball Players Association (NBPA) is the union for current professional basketball players in the National Basketball Association (NBA). Established in 1954, the NBPA mission is to ensure that the rights of NBA players are protected and that every conceivable measure is taken to assist players in maximizing their opportunities and achieving their goals, both on and off the court.
nbpa.com
November 25, 2025 at 3:56 PM
Congratulations to Tre Jones for this award and we are grateful for his support of cancer research! https://nbpa.com/news/chicago-bulls-tre-jones-named-nba-cares-bob-lanier-community-assist-award-winner-for-october
In a viewpoint, Sean Pitroda, MD and Ralph Weichselbaum, MD emphasizes the need to personalize treatment based on tumor biology, immune profiles, and metastatic patterns rather than relying on a single treatment. @JAMA Oncology Ludwig Cancer Research
https://ow.ly/BGBL50XvWcf
https://ow.ly/BGBL50XvWcf
November 21, 2025 at 5:39 PM
In a viewpoint, Sean Pitroda, MD and Ralph Weichselbaum, MD emphasizes the need to personalize treatment based on tumor biology, immune profiles, and metastatic patterns rather than relying on a single treatment. @JAMA Oncology Ludwig Cancer Research
https://ow.ly/BGBL50XvWcf
https://ow.ly/BGBL50XvWcf
A recent study published by Chuan He, PhD, and team reports that an ultra-mild bisulfite sequencing technique enables methylation sequencing both gentle and precise for ultra-low DNA inputs, providing a powerful tool to study epigenetic changes in cancer.
https://ow.ly/fMRw50XuP0f
https://ow.ly/fMRw50XuP0f
November 20, 2025 at 5:02 PM
A recent study published by Chuan He, PhD, and team reports that an ultra-mild bisulfite sequencing technique enables methylation sequencing both gentle and precise for ultra-low DNA inputs, providing a powerful tool to study epigenetic changes in cancer.
https://ow.ly/fMRw50XuP0f
https://ow.ly/fMRw50XuP0f
November is #LungCancerAwarenessMonth and one of our surgeons put together a helpful list of lung cancer myths & facts to www.uchicagomedicine.org/forefront/ca...
A great way to learn more and keep yourself safe!
A great way to learn more and keep yourself safe!
Clearing the air: 8 lung cancer myths, debunked - UChicago Medicine
UChicago Medicine thoracic surgeon Jessica Donington, MD, clears up several common misconceptions about lung cancer, including issues tied to smoking, screening and surgery.
www.uchicagomedicine.org
November 17, 2025 at 4:06 PM
November is #LungCancerAwarenessMonth and one of our surgeons put together a helpful list of lung cancer myths & facts to www.uchicagomedicine.org/forefront/ca...
A great way to learn more and keep yourself safe!
A great way to learn more and keep yourself safe!
Reposted by UChicago Cancer
Kunle Odunsi (@uchicagocancer.bsky.social): “One of the areas that I think we need to be thinking about as a community, cancer centers, is how do you reduce the dependence on federal funding to power the enterprise?"
https://cancerletter.com/podcastc/20251107_1/
https://cancerletter.com/podcastc/20251107_1/
The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery “This has always made our environment stronger, not weaker.” - The Cancer Letter
At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community. “Iwas born in Nigeria, I grew up in Nigeria, I went to medical school in Nigeria, and then I did some of […]
cancerletter.com
November 14, 2025 at 2:00 AM
Kunle Odunsi (@uchicagocancer.bsky.social): “One of the areas that I think we need to be thinking about as a community, cancer centers, is how do you reduce the dependence on federal funding to power the enterprise?"
https://cancerletter.com/podcastc/20251107_1/
https://cancerletter.com/podcastc/20251107_1/
A new study shows that inflammation caused by exposure to excessive sunlight degrades YTHDF2, a key protein that protects normal skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
November 14, 2025 at 8:13 PM
A new study shows that inflammation caused by exposure to excessive sunlight degrades YTHDF2, a key protein that protects normal skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
A new study shows that inflammation caused by excessive sunlight degrades YTHDF2, a key protein that protects normal skin skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social @UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
November 14, 2025 at 5:56 PM
A new study shows that inflammation caused by excessive sunlight degrades YTHDF2, a key protein that protects normal skin skin cells from turning cancerous, pointing towards ways to prevent skin cancer. UChicago Cancer @uchichemistry.bsky.social @UChicagoBSD
https://ow.ly/Z8hl50XrS8w
https://ow.ly/Z8hl50XrS8w
🔥Hot off the press: Chuan He, PhD and his team have developed a novel methylation analysis method called ultra-mild bisulfite sequencing, which detects epigenetic changes in cancers more quickly, accurately, and reliably than existing methods. @uchichemistry.bsky.social
https://ow.ly/ALtf50XrlC4
https://ow.ly/ALtf50XrlC4
November 13, 2025 at 9:04 PM
🔥Hot off the press: Chuan He, PhD and his team have developed a novel methylation analysis method called ultra-mild bisulfite sequencing, which detects epigenetic changes in cancers more quickly, accurately, and reliably than existing methods. @uchichemistry.bsky.social
https://ow.ly/ALtf50XrlC4
https://ow.ly/ALtf50XrlC4
What a week for new publications! Dr. Park has a new paper out in @cellpress.bsky.social Immunity about T cells! Read it at www.cell.com/immunity/ful...
#AtTheForefront #CancerImmunity #Tcells #OncSky
#AtTheForefront #CancerImmunity #Tcells #OncSky
Fermenting T cell stemness for cancer immunity
Gut microbial metabolites modulate immune responses to tumors. In this issue of Immunity,
Bachem et al. demonstrate that microbiota-derived butyrate cooperates with the transcription
factor Foxo1 to p...
www.cell.com
November 13, 2025 at 4:48 PM
What a week for new publications! Dr. Park has a new paper out in @cellpress.bsky.social Immunity about T cells! Read it at www.cell.com/immunity/ful...
#AtTheForefront #CancerImmunity #Tcells #OncSky
#AtTheForefront #CancerImmunity #Tcells #OncSky
🔥Hot off the press: In a new study, UChicago Cancer researchers show that restoring YTHDF2 function prevents normal skin cells from turning cancerous after excessive sun exposure. #UVRadiation #SkinCancer #Inflammation Nature Communications
https://www.nature.com/articles/s41467-025-64898-7
https://www.nature.com/articles/s41467-025-64898-7
November 12, 2025 at 6:45 PM
🔥Hot off the press: In a new study, UChicago Cancer researchers show that restoring YTHDF2 function prevents normal skin cells from turning cancerous after excessive sun exposure. #UVRadiation #SkinCancer #Inflammation Nature Communications
https://www.nature.com/articles/s41467-025-64898-7
https://www.nature.com/articles/s41467-025-64898-7
In a recent interview with OncLive, Wendy Stock, MD, discussed the growing role of TKIs in Ph-positive ALL, the impact of molecular monitoring on treatment optimization to maximize efficacy and safety/quality of life.
https://ow.ly/OyAG50Xq7zU
https://ow.ly/OyAG50Xq7zU
November 11, 2025 at 6:13 PM
In a recent interview with OncLive, Wendy Stock, MD, discussed the growing role of TKIs in Ph-positive ALL, the impact of molecular monitoring on treatment optimization to maximize efficacy and safety/quality of life.
https://ow.ly/OyAG50Xq7zU
https://ow.ly/OyAG50Xq7zU
Dr. @fredhow.bsky.social and colleagues from across the globe have a new article out in @aacrjournals.bsky.social's Clinical Cancer Research: aacrjournals.org/clincancerre...
Read on to learn how they've used machine learning to better predict recurrence risk and treatment efficacy!
Read on to learn how they've used machine learning to better predict recurrence risk and treatment efficacy!
Machine Learning–Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2– Early Breast Cancer Using Real-World and NATALEE Data
Abstract. Purpose: Despite current standard-of-care endocrine therapy, distant recurrence remains a concern for patients with HR+/HER2− early breast cancer (EBC). Understanding individual recurrence r...
aacrjournals.org
November 11, 2025 at 3:39 PM
Dr. @fredhow.bsky.social and colleagues from across the globe have a new article out in @aacrjournals.bsky.social's Clinical Cancer Research: aacrjournals.org/clincancerre...
Read on to learn how they've used machine learning to better predict recurrence risk and treatment efficacy!
Read on to learn how they've used machine learning to better predict recurrence risk and treatment efficacy!
Reposted by UChicago Cancer
“For someone like myself, I don’t think Yale would’ve paid $100,000 to get me an H-1B visa at the time, and I’m sure it’s going to be hard." - Kunle Odunsi (@uchicagocancer.bsky.social)
https://cancerletter.com/podcastc/20251107_1/
https://cancerletter.com/podcastc/20251107_1/
The Directors: Ruben Mesa and Kunle Odunsi on how immigration and diversity accelerate discovery “This has always made our environment stronger, not weaker.” - The Cancer Letter
At a time when federal immigration policies are becoming stricter, Kunle Odunsi, director of University of Chicago Medicine Comprehensive Cancer Center, reflected on the fact that cancer research is a highly international community. “Iwas born in Nigeria, I grew up in Nigeria, I went to medical school in Nigeria, and then I did some of […]
cancerletter.com
November 10, 2025 at 3:30 PM
“For someone like myself, I don’t think Yale would’ve paid $100,000 to get me an H-1B visa at the time, and I’m sure it’s going to be hard." - Kunle Odunsi (@uchicagocancer.bsky.social)
https://cancerletter.com/podcastc/20251107_1/
https://cancerletter.com/podcastc/20251107_1/
🎙️In the latest episode of The Director, Drs. Odunsi and Mesa emphasize that diversity, international collaboration, and continuous funding support are essential to bring transformative cancer therapies to clinics. Ruben A. Mesa, MD, FACP The Cancer Letter
https://ow.ly/Z8NR50XpG05
https://ow.ly/Z8NR50XpG05
November 10, 2025 at 9:36 PM
🎙️In the latest episode of The Director, Drs. Odunsi and Mesa emphasize that diversity, international collaboration, and continuous funding support are essential to bring transformative cancer therapies to clinics. Ruben A. Mesa, MD, FACP The Cancer Letter
https://ow.ly/Z8NR50XpG05
https://ow.ly/Z8NR50XpG05
📕New in Journal of Experimental Medicine: Chen et al., show that radiotherapy may promote metastasis by upregulating YTHDF2 in dendritic cells, impairing MHC-1 cross presentation and CD8+ T cell activation.
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
November 7, 2025 at 5:42 PM
📕New in Journal of Experimental Medicine: Chen et al., show that radiotherapy may promote metastasis by upregulating YTHDF2 in dendritic cells, impairing MHC-1 cross presentation and CD8+ T cell activation.
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
Ludwig Cancer Research
https://ow.ly/BAeq50Xown3
Researcher at the University of Chicago have developed a modular "plug-and-play" immune cell design that could make cancer immunotherapy treatments faster, smarter, and more adaptable.
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
November 5, 2025 at 8:53 PM
Researcher at the University of Chicago have developed a modular "plug-and-play" immune cell design that could make cancer immunotherapy treatments faster, smarter, and more adaptable.
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
#Immunotherapy #CART #NovelCancerTreatments
Read full story: https://ow.ly/mhpU50XnnNi
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
November 5, 2025 at 8:24 PM
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
UChicago's Post-ASH registration is open!! Coming up on January 30th, it will be a great overview of the highlights of this year's ASH! Find more at www.chicagopostash.com
Post ASH Annual Meeting - Hematology
University of Chicago Post ASH Annual Meeting - American Society of Hematology
www.chicagopostash.com
November 5, 2025 at 6:12 PM
UChicago's Post-ASH registration is open!! Coming up on January 30th, it will be a great overview of the highlights of this year's ASH! Find more at www.chicagopostash.com
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials @UCh
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
November 4, 2025 at 8:48 PM
Check out the inspiring story of Crystal Hendricks-Kretzer — a breast cancer survivor who benefited from a clinical trial that offered personalized breast cancer treatment using a novel antibody-drug conjugate. #BreastCancer #ClinicalTrials @UCh
https://ow.ly/46Zu50XmMAm
https://ow.ly/46Zu50XmMAm
A new article on alternative dosing strategies for oral cancer meds is out now from Drs. Wesevich & Ratain! You can find it at: www.sciencedirect.com/science/arti...
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
Potential alternative dosage strategies for patent-protected oral cancer drugs
To identify potential alternative dosage strategies for patent-protected oral oncology drugs that could reduce costs without decreasing efficacy for f…
www.sciencedirect.com
October 31, 2025 at 5:31 PM
A new article on alternative dosing strategies for oral cancer meds is out now from Drs. Wesevich & Ratain! You can find it at: www.sciencedirect.com/science/arti...
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
#AtTheForefront #MedicationDosing #CancerTreatment #OncSky
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
October 30, 2025 at 4:26 PM
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
UChicagoBSD
@uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
Former NIH director Monica Bertagnolli awarded the 2025 Simon M. Shubitz Cancer Prize
Bertagnolli, a renowned surgical oncologist and physician-scientist, was honored for her research on the role of genetics and inflammation in the development of cancer and her leadership in oncology clinical research.
ow.ly
October 29, 2025 at 10:04 PM
We were delighted to honor Monica Bertagnolli, MD, former @NIH and the NCI director, with the 2025 Simon M. Shubitz Prize for her leadership in oncology and commitment to advancing equitable cancer care.
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
UChicagoBSD @uchicagomedicine.bsky.social
https://ow.ly/vppj50XjTLY
We're excited to share that our cancer program has been named a Top 100 Oncology Program by Beckers Hospital Review!! SO proud of the incredible clinicians, researchers, and other team members who make this work possible every day!
www.beckershospitalreview.com/oncology/100...
www.beckershospitalreview.com/oncology/100...
100 hospitals and health systems with great oncology progra…
Becker’s Healthcare is proud to unveil its 2025 list of hospitals and health systems recognized for excellence in oncology. These leading institutions…
www.beckershospitalreview.com
October 29, 2025 at 4:09 PM
We're excited to share that our cancer program has been named a Top 100 Oncology Program by Beckers Hospital Review!! SO proud of the incredible clinicians, researchers, and other team members who make this work possible every day!
www.beckershospitalreview.com/oncology/100...
www.beckershospitalreview.com/oncology/100...
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research in tumor immunology and immunotherapy.
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
October 29, 2025 at 3:47 PM
Congrats to Thomas Gajewski, MD, PhD, on the 2025 AACI Distinguished Scientist Award recognizing his pioneering research in tumor immunology and immunotherapy.
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA
UChicagoBSD
University of Chicago Pathology
@uchicagomedicine.bsky.social
https://ow.ly/JMey50Xh2oA